UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q2 2022 | 2022-07-27 | Future report Set alerts | |
| Q1 2022 | 2022-05-05 | -0.22 | -0.22 |
| Q4 2021 | 2022-03-10 | -0.19 | -0.19 |
| Q3 2021 | 2021-10-28 | -0.05 | -0.05 |
| Q2 2021 | 2021-07-29 | -0.06 | -0.06 |
| Q1 2021 | 2021-04-29 | -0.17 | -0.17 |
| Q4 2020 | 2021-02-11 | -0.23 | -0.23 |
| Q3 2020 | 2020-10-29 | 0.00 | 0.00 |
| Q2 2020 | 2020-07-23 | -0.39 | -0.39 |
| Q1 2020 | 2020-04-30 | -0.46 | -0.46 |
| 2016-06-10 | Reiterated Rating | FBR & Co. | Buy | |
| 2016-06-10 | Reiterated Rating | FBR & Co | Buy | |
| 2016-04-01 | Reiterated Rating | Needham & Company LLC | Buy | $15.00 |
| 2016-04-01 | Reiterated Rating | FBR & Co. | Buy | $17.00 |
| 2016-04-01 | Boost Price Target | Stifel Nicolaus | Buy | $11.00 to $13.00 |
| 2016-02-12 | Reiterated Rating | FBR & Co. | Outperform | $17.00 |
| 2016-02-01 | Reiterated Rating | FBR & Co. | Outperform | |
| 2015-11-05 | Reiterated Rating | Needham & Company LLC | Buy | $15.00 |
| 2015-10-19 | Reiterated Rating | Piper Jaffray | Buy | |
| 2015-10-19 | Lower Price Target | FBR & Co. | Outperform | $20.00 to $17.00 |
| 2015-10-19 | Lower Price Target | Needham & Company LLC | Buy | $22.00 to $15.00 |
| 2015-10-19 | Reiterated Rating | Piper Jaffray Cos. | Buy | |
| 2015-10-08 | Reiterated Rating | Needham & Company LLC | Buy | $22.00 |
| 2015-10-07 | Reiterated Rating | FBR & Co. | Buy | $20.00 |
| 2015-10-07 | Reiterated Rating | Cowen and Company | Buy | $40.00 |
| 2015-08-10 | Reiterated Rating | Needham & Company LLC | Buy | $22.00 |
| 2015-08-06 | Reiterated Rating | Piper Jaffray | Overweight | $18.00 to $19.00 |
| 2015-05-20 | Reiterated Rating | FBR & Co. | Buy | |
| 2015-05-19 | Reiterated Rating | Piper Jaffray | Overweight | $14.00 |
| 2015-05-07 | Set Price Target | Needham & Company LLC | Buy | $22.00 |
| 2015-04-20 | Initiated Coverage | FBR & Co. | Outperform | $20.00 |
| 2015-03-18 | Initiated Coverage | Piper Jaffray | Overweight | $14.00 |
| 2014-11-07 | Reiterated Rating | Stifel Nicolaus | Positive to Buy | $29.00 to $24.00 |
| 2014-03-05 | Initiated | Needham | Buy | $22 |
| 2014-03-05 | Initiated Coverage | Needham & Company LLC | Buy | $22.00 |
| 2014-03-03 | Initiated Coverage | Stifel Nicolaus | Buy | $25.00 |
| 2014-03-03 | Initiated Coverage | Cowen and Company | Outperform | $40.00 |
| 2014-03-03 | Initiated Coverage | Citigroup Inc. | Buy |
| 2016-06-10 | Reiterated Rating | FBR & Co. | Buy | |
| 2016-06-10 | Reiterated Rating | FBR & Co | Buy | |
| 2016-04-01 | Reiterated Rating | Needham & Company LLC | Buy | $15.00 |
| 2016-04-01 | Reiterated Rating | FBR & Co. | Buy | $17.00 |
| 2016-04-01 | Boost Price Target | Stifel Nicolaus | Buy | $11.00 to $13.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In GNCA 0 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| Bitterman Kevin | 12.23% (2128678) | GNCA / |
| HOFFMAN STEPHEN J | 11.44% (1992415) | ACRX / DRNA / GNCA / |
| Polaris Venture Management Co. V, L.L.C. | 11.31% (1968606) | BIND / CERU / FATE / GNCA / TRVN / |
| Lux Capital Management, LLC Former 10% Owner | 9.66% (1682037) | CERU / GNCA / |
| George Simeon | 9.60% (1671667) | GNCA / |
| GLAXOSMITHKLINE PLC Former 10% Shareholder | 9.60% (1671667) | AGTC / CNCE / FOLD / GNCA / OMED / PATH / TBPH / THRX / |
| JOHNSON & JOHNSON | 7.98% (1388645) | ACHN / ALDX / AQXP / GNCA / JNJ / NERV / NVRO / TNGN / |
| Poole Jonathan Chief Financial Officer | 0.48% (84247) | GNCA / |
| Clark William D President and CEO | 0.48% (82931) | GNCA / VNDA / |
| HETHERINGTON SETH V Chief Medical Officer | 0.12% (21000) | GNCA / |
| Siber George | 0.08% (13247) | GNCA / |
| Flechtner Jessica Baker VP of Research | 0.06% (10787) | GNCA / |
UM